TapewireFind a company

organization · Reporting owner

EW Healthcare Partners Fund 2-UGP, LLC

Disclosed activity across 1 company

Tapewire entity
73067
SEC CIK
0001793948

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TELA Bio, Inc.TELA · Entity 738110% owner · See RemarksNovember 17, 2025November 17, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.001 per shareSEC Table I · non-derivativeDirect7,714,709 Reported balance After 2025-11-17 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2025-11-17 · Purchase · Acquired 3,604,000 · Balance 7,714,709

F1: Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P.

Filing footnotes · ownership attribution and instrument terms

F1: Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 04, 2022 Filed May 4, 2022 17:53 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.53 $47,650.00
Disclosure

SEC source: 0000899243-22-016664 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,370,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,500 shares of the amount shown for each date above, and Fund 2-A purchased 3,500 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,364,011 shares and Fund 2-A now holds a total of 2,006,698 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 03, 2022 Filed May 4, 2022 17:53 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.40 $47,000.00
Disclosure

SEC source: 0000899243-22-016664 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,365,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,500 shares of the amount shown for each date above, and Fund 2-A purchased 3,500 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,364,011 shares and Fund 2-A now holds a total of 2,006,698 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 02, 2022 Filed May 4, 2022 17:53 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.32 $46,600.00
Disclosure

SEC source: 0000899243-22-016664 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,360,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,500 shares of the amount shown for each date above, and Fund 2-A purchased 3,500 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,364,011 shares and Fund 2-A now holds a total of 2,006,698 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 29, 2022 Filed Apr 29, 2022 18:10 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.17 $45,850.00
Disclosure

SEC source: 0000899243-22-016040 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,355,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares of the amount shown for each date above, and Fund 2-A purchased 3,035 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,359,511 shares and Fund 2-A now holds a total of 1,996,198 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 28, 2022 Filed Apr 29, 2022 18:10 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.09 $45,450.00
Disclosure

SEC source: 0000899243-22-016040 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,350,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares of the amount shown for each date above, and Fund 2-A purchased 3,035 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,359,511 shares and Fund 2-A now holds a total of 1,996,198 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 27, 2022 Filed Apr 29, 2022 18:10 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.05 $45,250.00
Disclosure

SEC source: 0000899243-22-016040 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,345,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares of the amount shown for each date above, and Fund 2-A purchased 3,035 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,359,511 shares and Fund 2-A now holds a total of 1,996,198 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 26, 2022 Filed Apr 27, 2022 11:31 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 10,000 $9.24 $92,400.00
Disclosure

SEC source: 0000899243-22-015733 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,340,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares and 3,930 shares of the amount shown above for April 25, 2022 and April 26, 2022, respectively, and Fund 2-A purchased 3,035 shares and 6,070 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,353,616 shares and Fund 2-A now holds a total of 1,987,093 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 11:31 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.49 $47,450.00
Disclosure

SEC source: 0000899243-22-015733 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,330,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares and 3,930 shares of the amount shown above for April 25, 2022 and April 26, 2022, respectively, and Fund 2-A purchased 3,035 shares and 6,070 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,353,616 shares and Fund 2-A now holds a total of 1,987,093 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 19, 2022 Filed Apr 19, 2022 19:01 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 3,200 $9.84 $31,488.00
Disclosure

SEC source: 0000899243-22-015076 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,325,709

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 231 shares, 1,965 shares and 1,257 shares of the amount shown above for April 14, 2022, April 18, 2022, and April 19, 2022, respectively, and Fund 2-A purchased 358 shares, 3,035 shares and 1,943 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,347,721 shares and Fund 2-A now holds a total of 1,977,988 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 18, 2022 Filed Apr 19, 2022 19:01 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $9.80 $49,000.00
Disclosure

SEC source: 0000899243-22-015076 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,322,509

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 231 shares, 1,965 shares and 1,257 shares of the amount shown above for April 14, 2022, April 18, 2022, and April 19, 2022, respectively, and Fund 2-A purchased 358 shares, 3,035 shares and 1,943 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,347,721 shares and Fund 2-A now holds a total of 1,977,988 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 14, 2022 Filed Apr 19, 2022 19:01 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 589 $10.00 $5,890.00
Disclosure

SEC source: 0000899243-22-015076 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,317,509

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 231 shares, 1,965 shares and 1,257 shares of the amount shown above for April 14, 2022, April 18, 2022, and April 19, 2022, respectively, and Fund 2-A purchased 358 shares, 3,035 shares and 1,943 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,347,721 shares and Fund 2-A now holds a total of 1,977,988 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 01, 2022 Filed Apr 4, 2022 12:59 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 684 $11.45 $7,831.80
Disclosure

SEC source: 0000899243-22-013262 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,316,920

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares and 269 shares of the amount shown above for March 31, 2022 and April 1, 2022, respectively, and Fund 2-A purchased 3,035 shares and 415 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,344,268 shares and Fund 2-A now holds a total of 1,972,652 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 12:59 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $11.54 $57,700.00
Disclosure

SEC source: 0000899243-22-013262 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,316,236

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 shares and 269 shares of the amount shown above for March 31, 2022 and April 1, 2022, respectively, and Fund 2-A purchased 3,035 shares and 415 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,344,268 shares and Fund 2-A now holds a total of 1,972,652 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 30, 2022 Filed Mar 31, 2022 12:01 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 2,645 $11.65 $30,814.25
Disclosure

SEC source: 0000899243-22-012918 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,311,236

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,199 shares and 1,039 shares of the amount shown above for March 29, 2022 and March 30, 2022, respectively, and Fund 2-A purchased 1,853 shares and 1,606 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,342,034 shares and Fund 2-A now holds a total of 1,969,202 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 29, 2022 Filed Mar 31, 2022 12:01 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 3,052 $11.65 $35,555.80
Disclosure

SEC source: 0000899243-22-012918 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,308,591

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,199 shares and 1,039 shares of the amount shown above for March 29, 2022 and March 30, 2022, respectively, and Fund 2-A purchased 1,853 shares and 1,606 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,342,034 shares and Fund 2-A now holds a total of 1,969,202 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 22, 2022 Filed Mar 24, 2022 17:57 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 136 $11.65 $1,584.40
Disclosure

SEC source: 0000899243-22-012127 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,305,539

F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 0 shares of the amount shown above, and Fund 2-A purchased 136 shares of the amount shown above on such date. Fund 2 now holds a total of 1,339,796 shares and Fund 2-A now holds a total of 1,965,743 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 16, 2022 Filed Mar 16, 2022 20:28 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 2,331 $11.65 $27,156.15
Disclosure

SEC source: 0000899243-22-011303 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,305,403

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,365 shares, 100 shares, and 856 shares of the amounts shown above for March 14, 2022, March 15, 2022, and March 16, 2022, respectively, and Fund 2-A purchased 2,108 shares, 0 shares, and 1,475 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,339,796 shares and Fund 2-A now holds a total of 1,965,607 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 15, 2022 Filed Mar 16, 2022 20:28 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 100 $11.65 $1,165.00
Disclosure

SEC source: 0000899243-22-011303 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,303,072

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,365 shares, 100 shares, and 856 shares of the amounts shown above for March 14, 2022, March 15, 2022, and March 16, 2022, respectively, and Fund 2-A purchased 2,108 shares, 0 shares, and 1,475 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,339,796 shares and Fund 2-A now holds a total of 1,965,607 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 20:28 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 3,473 $11.68 $40,564.64
Disclosure

SEC source: 0000899243-22-011303 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,302,972

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,365 shares, 100 shares, and 856 shares of the amounts shown above for March 14, 2022, March 15, 2022, and March 16, 2022, respectively, and Fund 2-A purchased 2,108 shares, 0 shares, and 1,475 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,339,796 shares and Fund 2-A now holds a total of 1,965,607 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 24, 2022 Filed Feb 24, 2022 18:55 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,572 $11.74 $65,415.28
Disclosure

SEC source: 0000899243-22-007737 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,299,499

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,406 shares, 294,982 shares, and 2,190 shares of the amounts shown above for February 22, 2022, February 23, 2022, and February 24, 2022, respectively, and Fund 2-A purchased 2,173 shares, 455,675 shares, and 3,382 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,337,475 shares and Fund 2-A now holds a total of 1,962,024 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 23, 2022 Filed Feb 24, 2022 18:55 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 750,657 $11.75 $8,820,219.75
Disclosure

SEC source: 0000899243-22-007737 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,293,927

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,406 shares, 294,982 shares, and 2,190 shares of the amounts shown above for February 22, 2022, February 23, 2022, and February 24, 2022, respectively, and Fund 2-A purchased 2,173 shares, 455,675 shares, and 3,382 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,337,475 shares and Fund 2-A now holds a total of 1,962,024 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 18:55 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 3,579 $11.74 $42,017.46
Disclosure

SEC source: 0000899243-22-007737 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,543,270

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,406 shares, 294,982 shares, and 2,190 shares of the amounts shown above for February 22, 2022, February 23, 2022, and February 24, 2022, respectively, and Fund 2-A purchased 2,173 shares, 455,675 shares, and 3,382 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,337,475 shares and Fund 2-A now holds a total of 1,962,024 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 18, 2022 Filed Feb 18, 2022 20:48 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 2,520 $11.75 $29,610.00
Disclosure

SEC source: 0000899243-22-007089 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,539,691

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,026 shares, 2,676 shares, and 990 shares of the amounts shown above for February 16, 2022, February 17, 2022, and February 18, 2022, respectively, and Fund 2-A purchased 6,974 shares, 4,134 shares, and 1,530 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,038,897 shares and Fund 2-A now holds a total of 1,500,794 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 17, 2022 Filed Feb 18, 2022 20:48 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 6,810 $11.73 $79,881.30
Disclosure

SEC source: 0000899243-22-007089 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,537,171

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,026 shares, 2,676 shares, and 990 shares of the amounts shown above for February 16, 2022, February 17, 2022, and February 18, 2022, respectively, and Fund 2-A purchased 6,974 shares, 4,134 shares, and 1,530 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,038,897 shares and Fund 2-A now holds a total of 1,500,794 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 20:48 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 10,000 $11.72 $117,200.00
Disclosure

SEC source: 0000899243-22-007089 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,530,361

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,026 shares, 2,676 shares, and 990 shares of the amounts shown above for February 16, 2022, February 17, 2022, and February 18, 2022, respectively, and Fund 2-A purchased 6,974 shares, 4,134 shares, and 1,530 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,038,897 shares and Fund 2-A now holds a total of 1,500,794 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 15, 2022 Filed Feb 16, 2022 16:24 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 29 $11.75 $340.75
Disclosure

SEC source: 0000899243-22-006640 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,520,361

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 0 shares and 0 shares of the amounts shown above for February 14, 2022 and February 15, 2022, respectively, and Fund 2-A purchased 10 shares and 29 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,032,205 shares and Fund 2-A now holds a total of 1,488,156 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 16:24 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 10 $11.75 $117.50
Disclosure

SEC source: 0000899243-22-006640 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,520,332

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 0 shares and 0 shares of the amounts shown above for February 14, 2022 and February 15, 2022, respectively, and Fund 2-A purchased 10 shares and 29 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,032,205 shares and Fund 2-A now holds a total of 1,488,156 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 11, 2022 Filed Feb 14, 2022 17:50 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 7,082 $11.74 $83,142.68
Disclosure

SEC source: 0000899243-22-006233 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,520,322

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 0 shares and 2,987 shares of the amounts shown above for February 10, 2022 and February 11, 2022, respectively, and Fund 2-A purchased 520 shares and 4,095 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,032,205 shares and Fund 2-A now holds a total of 1,488,117 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 17:50 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 520 $11.75 $6,110.00
Disclosure

SEC source: 0000899243-22-006233 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,513,240

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 0 shares and 2,987 shares of the amounts shown above for February 10, 2022 and February 11, 2022, respectively, and Fund 2-A purchased 520 shares and 4,095 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,032,205 shares and Fund 2-A now holds a total of 1,488,117 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 09, 2022 Filed Feb 10, 2022 17:27 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 1,327 $11.75 $15,592.25
Disclosure

SEC source: 0000899243-22-005630 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,512,720

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 0 shares and 718 shares of the amounts shown above for February 8, 2022 and February 9, 2022, respectively, and Fund 2-A purchased 500 shares and 609 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,029,218 shares and Fund 2-A now holds a total of 1,483,502 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 17:27 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 500 $11.75 $5,875.00
Disclosure

SEC source: 0000899243-22-005630 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,511,393

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 0 shares and 718 shares of the amounts shown above for February 8, 2022 and February 9, 2022, respectively, and Fund 2-A purchased 500 shares and 609 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,029,218 shares and Fund 2-A now holds a total of 1,483,502 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 31, 2022 Filed Feb 1, 2022 13:26 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 1,950 $11.74 $22,893.00
Disclosure

SEC source: 0000899243-22-003797 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,510,893

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 766 shares of the amounts shown above for January 28, 2022 and January 31, 2022, respectively, and Fund 2-A purchased 3,035 and 1,184 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,028,500 shares and Fund 2-A now holds a total of 1,482,393 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 13:26 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $11.33 $56,650.00
Disclosure

SEC source: 0000899243-22-003797 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,508,943

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 766 shares of the amounts shown above for January 28, 2022 and January 31, 2022, respectively, and Fund 2-A purchased 3,035 and 1,184 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,028,500 shares and Fund 2-A now holds a total of 1,482,393 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 27, 2022 Filed Jan 28, 2022 18:06 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $11.51 $57,550.00
Disclosure

SEC source: 0000899243-22-003575 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,503,943

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,962 and 1,965 shares of the amounts shown above for January 26, 2022 and January 27, 2022, respectively, and Fund 2-A purchased 3,031 and 3,035 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,025,769 shares and Fund 2-A now holds a total of 1,478,174 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 26, 2022 Filed Jan 28, 2022 18:06 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 4,993 $11.74 $58,617.82
Disclosure

SEC source: 0000899243-22-003575 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,498,943

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,962 and 1,965 shares of the amounts shown above for January 26, 2022 and January 27, 2022, respectively, and Fund 2-A purchased 3,031 and 3,035 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,025,769 shares and Fund 2-A now holds a total of 1,478,174 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 11:49 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 3,846 $11.92 $45,844.32
Disclosure

SEC source: 0000899243-22-003247 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,493,950

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 1,511 shares of the amounts shown above for January 24, 2022 and January 25, 2022, respectively, and Fund 2-A purchased 3,035 and 2,335 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,021,842 shares and Fund 2-A now holds a total of 1,472,108 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 24, 2022 Filed Jan 26, 2022 11:49 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $11.68 $58,400.00
Disclosure

SEC source: 0000899243-22-003247 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,490,104

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 1,511 shares of the amounts shown above for January 24, 2022 and January 25, 2022, respectively, and Fund 2-A purchased 3,035 and 2,335 shares of the amounts shown above on each such date. Fund 2 now holds a total of 1,021,842 shares and Fund 2-A now holds a total of 1,472,108 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 12:52 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 567,467 $12.00 $6,809,604.00
Disclosure

SEC source: 0000899243-22-002300 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,485,104

F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 223,015 shares of the amount shown above, and Fund 2-A purchased 344,452 shares of the amount shown above. Fund 2 now holds a total of 1,018,366 shares and Fund 2-A now holds a total of 1,466,738 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 12, 2022 Filed Jan 14, 2022 17:24 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $12.50 $62,500.00
Disclosure

SEC source: 0000899243-22-002019 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,917,637

F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 1,965 shares of the amount shown above, and Fund 2-A purchased 3,035 shares of the amount shown above. Fund 2 now holds a total of 795,351 shares and Fund 2-A now holds a total of 1,122,286 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 11, 2022 Filed Jan 12, 2022 17:25 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $12.38 $61,900.00
Disclosure

SEC source: 0000899243-22-001780 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,912,637

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 554 shares and 1,965 shares of the amount shown above for January 10 and January 11, respectively, and Fund 2-A purchased 855 shares and 3,035 shares of the amount shown above on each such date, respectively. Fund 2 now holds a total of 793,386 shares and Fund 2-A now holds a total of 1,119.251 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 17:25 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 1,409 $12.46 $17,556.14
Disclosure

SEC source: 0000899243-22-001780 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,907,637

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 554 shares and 1,965 shares of the amount shown above for January 10 and January 11, respectively, and Fund 2-A purchased 855 shares and 3,035 shares of the amount shown above on each such date, respectively. Fund 2 now holds a total of 793,386 shares and Fund 2-A now holds a total of 1,119.251 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:24 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,928 $12.46 $73,862.88
Disclosure

SEC source: 0000899243-22-000689 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,906,228

F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 2,330 shares of the amount shown above and Fund 2-A purchased 3,598 shares of the amount shown above. Fund 2 now holds a total of 790,867 shares and Fund 2-A now holds a total of 1,115,361 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 17:43 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 4,300 $12.22 $52,546.00
Disclosure

SEC source: 0000899243-21-049415 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,900,300

F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 1,690 shares of the amount shown above and Fund 2-A purchased 2,610 shares of the amount shown above. Fund 2 now holds a total of 788,537 shares and Fund 2-A now holds a total of 1,111,763 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 16, 2021 Filed Dec 17, 2021 17:40 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,050 $12.45 $62,872.50
Disclosure

SEC source: 0000899243-21-048822 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,896,000

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 1,984 shares of the amounts shown above for December 15 and December 16, respectively, and Fund 2-A purchased 3,035 and 3,066 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 786,847 shares and Fund 2-A now holds a total of 1,109,153 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 17:40 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 5,000 $12.43 $62,150.00
Disclosure

SEC source: 0000899243-21-048822 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,890,950

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 1,984 shares of the amounts shown above for December 15 and December 16, respectively, and Fund 2-A purchased 3,035 and 3,066 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 786,847 shares and Fund 2-A now holds a total of 1,109,153 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 14, 2021 Filed Dec 14, 2021 17:50 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 10,000 $12.33 $123,300.00
Disclosure

SEC source: 0000899243-21-048156 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,885,950

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 545 and 3,930 shares of the amounts shown above for December 10 and December 14, respectively, and Fund 2-A purchased 842 and 6,070 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 782,898 shares and Fund 2-A now holds a total of 1,103,052 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 10, 2021 Filed Dec 14, 2021 17:50 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 1,387 $12.49 $17,323.63
Disclosure

SEC source: 0000899243-21-048156 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,875,950

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 545 and 3,930 shares of the amounts shown above for December 10 and December 14, respectively, and Fund 2-A purchased 842 and 6,070 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 782,898 shares and Fund 2-A now holds a total of 1,103,052 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 08, 2021 Filed Dec 8, 2021 18:47 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 1,425 $12.39 $17,655.75
Disclosure

SEC source: 0000899243-21-047397 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,874,563

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,930, 4,381 and 560 shares of the amounts shown above for December 6, December 7 and December 8, respectively, and Fund 2-A purchased 6,070, 6,767 and 865 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 778,423 shares and Fund 2-A now holds a total of 1,096,140 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 07, 2021 Filed Dec 8, 2021 18:47 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 11,148 $12.32 $137,343.36
Disclosure

SEC source: 0000899243-21-047397 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,873,138

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,930, 4,381 and 560 shares of the amounts shown above for December 6, December 7 and December 8, respectively, and Fund 2-A purchased 6,070, 6,767 and 865 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 778,423 shares and Fund 2-A now holds a total of 1,096,140 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
December 06, 2021 Filed Dec 8, 2021 18:47 UTC TELA Bio, Inc. TELA · Entity 7381 PurchaseCommon Stock, par value $0.001 per share 10,000 $12.39 $123,900.00
Disclosure

SEC source: 0000899243-21-047397 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,861,990

F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,930, 4,381 and 560 shares of the amounts shown above for December 6, December 7 and December 8, respectively, and Fund 2-A purchased 6,070, 6,767 and 865 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 778,423 shares and Fund 2-A now holds a total of 1,096,140 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.